- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04659837
Training Response Inhibition to Obesogenic Foods
December 2, 2020 updated by: Drexel University
Reducing Cancer Risk by Training Response Inhibition to Obesogenic Foods
Dietary choices, and in particular, excess calorie intake leading to obesity, are strong, but reversible risk factors for cancer.
For example, foods high in added sugars are low-nutrient, high calorie foods that increase the risk of cancer by promoting weight gain.
As such, the reduction of sweets is consistent with American Institute for Cancer Research and the American Cancer Society dietary recommendations.
Behavioral interventions to alter diet have limited long-term efficacy, most likely because eating decisions are governed by automatic neurocognitive processes that are not addressed in conventional interventions.
In particular, the ability to refrain from consuming unhealthy, but widely available, palatable foods, is increasingly understood to depend on inhibitory control, i.e., the ability to cut off action tendencies that are put in motion by innate drives towards rewarding behaviors.
Recent work by our team and others have demonstrated that computer-based inhibitory control trainings result in short-term, specific changes in behavior, such as reducing intake of salty snack food, chocolate, and alcoholic beverages.
An automatized, home computer-based inhibitory control training offers the potential of an inexpensive and highly disseminable method of lowering cancer risk across wide swaths of the population.
As such, we aim to evaluate the feasibility, acceptability, mechanism of action, effectiveness and persistence of a home computer-based inhibitory control training.
In particular, we hypothesize that a high-repetition training in inhibitory control will result in increased adherence to a low-sugar diet, and that effects will be mediated through improved inhibitory control.
We further hypothesize that gamefying the training will improve efficacy because it will boost compliance with the daily trainings.
We also hypothesize that the training will be most effective for those starting of with impaired inhibitory control, as well as those with strongest desire for palatable foods and those with strongest explicit health goals.
Lastly, we aim to examine the impact of inhibitory control training on secondary outcomes, including on overall caloric intake, and on short-term weight loss.
To achieve these aims, the proposed study will recruit 100 overweight and obese individuals who currently eat high-sugar diets, and who wish to improve their diets.
Participants will be assigned a reduced-sugar diet for 8 weeks.
After a baseline period, participants will be randomized, via a 2 x 2 factorial design, to receive 6 weeks of either inhibitory control training or a sham training, and either a gamified or non-gameified training.
The 6-week intervention will consist of 15 minutes per day of home computer- based inhibitory control training, and will be followed by a 1-week booster and then 1-week follow-up period.
Dietary adherence will be measured via a food frequency questionnaire and via automated 24-hour food recall.
Neurocognitive variables will be assessed pre and post-training in order to test trainings' mechanism of action, and moderation will be assessed through baseline trait measures of explicit health goals, implicit attitudes towards appetitive stimuli, body mass index, and responsivity to food cues.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
125
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- Drexel University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- BMI 25-50
- Baseline consumption of ≥ 3 servings/day of high-sugar foods
Exclusion Criteria:
- Medical or psychiatric conditions that could interfere with the ability to comply with diet recommendations,
- pregnancy (or planning to become pregnant in the next 12 months) or current breastfeeding,
- a history of bariatric surgery,
- weight loss of five percent or more within the last six months
- beginning or changing a dosage of a weight-affecting medication within the last three months
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: FACTORIAL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: Inhibitory Control Training
Active Inhibitory Control Training vs. Sham Inhibitory Control Training
|
All participants received a no-added-sugar dietary intervention and followed the diet during the course of the study.
|
|
OTHER: Gameification
Gameified elements added vs.
No gameified elements added
|
All participants received a no-added-sugar dietary intervention and followed the diet during the course of the study.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Weight
Time Frame: 8 weeks
|
8 weeks
|
|
|
Sweets consumption
Time Frame: 8 weeks
|
8 weeks
|
|
|
Inhibitory control in response to high-sugar foods
Time Frame: 8 weeks
|
Inhibitory control in response to high-sugar foods is measured via performance (i.e., speed of inhibiting prepotent responses to high-sugar food stimuli) on the daily inhibitory control training (i.e., Go/No-Go) task.
|
8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Compliance with daily inhibitory control training prescription
Time Frame: 8 weeks
|
Compliance with completing the daily inhibitory control training prescription will be measured as the number of days the task was completed out of the total number of days it was prescribed.
|
8 weeks
|
|
Enjoyment of the daily training task
Time Frame: 8 weeks
|
Enjoyment and acceptability of the inhibitory control training will be assessed using self-report.
Participants will be asked to rate how 'fun' and 'boring' the training was on a Likert scale.
|
8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
June 1, 2016
Primary Completion (ACTUAL)
August 7, 2019
Study Completion (ACTUAL)
December 1, 2019
Study Registration Dates
First Submitted
July 21, 2020
First Submitted That Met QC Criteria
December 2, 2020
First Posted (ACTUAL)
December 9, 2020
Study Record Updates
Last Update Posted (ACTUAL)
December 9, 2020
Last Update Submitted That Met QC Criteria
December 2, 2020
Last Verified
December 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- R21CA191859 (NIH)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Inhibitory Control Training
-
Namik Kemal UniversityPrincess Nourah Bint Abdulrahman UniversityCompletedMotor Skills | Physical Fitness | Inhibitory ControlTurkey
-
Universidad Vina del MarCompletedContraceptive Usage | Diffuse Noxious Inhibitory ControlChile
-
Texas Tech University Health Sciences CenterCompletedWell-being | Inhibitory Control | Psychomotor Speed | Sustained Attention | Memory EncodingUnited States
-
University of BernRecruitingSuicidal Ideation | Suicide, Attempted | Self Efficacy | Attention | Locus of Control | Inhibitory ControlSwitzerland
-
University of California, San FranciscoNational Institute on Aging (NIA)RecruitingMild Cognitive Impairment | Inhibitory Control | Long-Term MemoryUnited States
-
University of California, San FranciscoNational Institute on Aging (NIA)RecruitingMild Cognitive Impairment (MCI) | Aging | Working Memory | Inhibitory ControlUnited States
-
University of ValenciaNot yet recruitingControl Group | Training Group
-
University of MiamiCompleted
-
Oregon Research InstituteCompletedIntervention (Training) Condition | Control (Delayed Training) Condition
-
University College, LondonActive, not recruitingWaitlist Control | Intervention (Training) ConditionUnited Kingdom
Clinical Trials on No-Added-Sugar Diet
-
University of DelawareNational Institute of General Medical Sciences (NIGMS)CompletedAging | Healthy DietUnited States
-
Virginia Polytechnic Institute and State UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedValidation StudiesUnited States
-
USDA Grand Forks Human Nutrition Research CenterCompleted
-
Shiraz University of Medical SciencesCompletedHypertensionIran, Islamic Republic of
-
National Taiwan Sport UniversityCompletedCardiovascular Diseases | Dyslipidemias | HypercholesterolemiaTaiwan
-
University of Texas Southwestern Medical CenterTerminated
-
University of DelawareCompletedHealthy Aging | Healthy DietUnited States
-
Emory UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingCystic Fibrosis | Cystic Fibrosis-related DiabetesUnited States
-
University of North Carolina, Chapel HillNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedObesity | Weight GainUnited States
-
Luc Tappy, MDAgroscope Liebfeld Posieux, Liebfeld-Bern SwitzerlandCompleted